Abstract
Angina pectoris due to coronary artery disease is generally considered to be chest pain due to myocardial ischemia which occurs because the myocardial oxygen demand exceeds the myocardial oxygen supply. An effective antianginal agent should relieve anginal pain either by improving the myocardial oxygen supply or by reducing the myocardial oxygen demand. In addition to relieving anginal pain, an ideal antianginal drug would also increase exercise performance, reduce electrocardiographic evidence of myocardial ischemia, prevent myocardial infarction, and prolong life. The following discussion will critically evaluate the efficacy of the nitrites as antianginal drugs.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aronow, W.S.: Drug evaluation—Chronic trials, in Ross, R.S. and Hoffman, F., editors: Myocardial Ischemia, International Congress Series No. 225, Amsterdam, 1971, Excerpta Medica, pp. 73–82.
Aronow, W. S.: The medical treatment of angina pectoris II. Design of an antianginal drug study. Amer. Heart J. 84, 132–134 (1972a).
Aronow, W.S.: Medical treatment of angina pectoris. III. Pharmacology of sublingual nitrites as antianginal drugs. Amer. Heart J. 84, 273–275 (1972b).
Aronow, W.S.: The medical treatment of angina pectoris. IV. Nitroglycerin as an antianginal drug. Amer. Heart J. 8, 415–418 (1972c).
Aronow, W.S.: The medical treatment of angina pectoris. V. Long-acting nitrites as antianginal drugs. Amer. Heart J. 84, 567–569 (1972d).
Aronow, W.S.: The medical treatment of angina pectoris. IX. The medical management of angina pectoris. Amer. Heart J. 85, 275–278 (1973a).
Aronow, W.S.: Management of stable angina. New Engl. J. Med. 289, 516–520 (1973b).
Aronow, W.S., Chesluk, H.M.: Sublingual isosorbide dinitrate therapy versus sublingual placebo in angina pectoris. Circulation 41, 869–874 (1970a).
Aronow, W.S., Chesluk, H.M.: Evaluation of nitroglycerin in angina in patients on isosorbide dinitrate. Circulation 42, 61–63 (1970b).
Aronow, W.S., Kaplan, M.A.: Evaluation of propranolol and of isosorbide dinitrate in angina pectoris. Curr. Ther. Res. 11, 80–86 (1969).
Battock, D.J., Alvarez, H., Chidsey, C.A.: Effect of propranolol and isosorbide dinitrate on exercise performance and adrenergic activity in patients with angina pectoris. Circulation 39, 157–169 (1969).
Battock, D. J., Chidsey, C.A.: Isosorbide dinitrate in angina. Circulation 44, 1147 (1971) (Letter to the Editor).
Bernstein, L., Friesinger, G.C., Lichtlen, P.R., Ross, R.S.: The effect of nitroglycerin on the systemic and coronary circulation in man and dogs. Myocardial blood flow measured with xenon. Circulation 33, 107–116 (1966).
Burch, G.E., DePasquale, N.P.: Fresh nitroglycerin (glyceryl trinitrate). Amer. Heart J. 72, 842 (1966).
Cole, S.L., Kaye, H., Griffith, G. C.: Assay of anti-anginal agents I. A curve analysis with multiple control periods. Circulation 15, 405–413 (1957).
Cole, S.L., Kaye, H., Griffith, G. C.: Assay of antianginal agents. A long-acting nitrate, psychic energizers and a tranquilizer. Amer. J. Cardiol. 11, 639–645 (1963).
Dagenais, G.R., Mason, R.E., Friesinger, G.C., Wender, C., Ross, R.S.: Exercise tolerance in patients with angina pectoris: Daily variation and effect of pentaerythritol tetranitrate. John Hopkins med. J. 125, 301–311 (1969).
Detry, J.M., Bruce, R.A.: Effects of nitroglycerin on “maximal” oxygen intake and exercise electrocardiogram in coronary heart disease. Circulation 43, 155–163 (1971).
Dewar, H.A., Horler, A.R., Newell, D.J.: A clinical trial of penta-erythritol tetranitrate, a khellin derivative (recordil), and iproniazid in angina of effort. Brit. Heart J. 21, 315–322 (1959).
Evans, W., Hoyle, C.: The comparative value of drugs used in the continuous treatment of angina pectoris. Quart. J. med. 2, 311–338 (1933).
Fisch, S., DeGraff.A.C.: Coronary vasodilators. Dis Chest 44, 533–537 (1963).
Freis, E.D., Gaffney, T.E., Kirkendall, W., Marcus, F. I., Nickerson, M., Pearce, M.L.: Report of the panels on cardiovascular drugs from the drug efficacy study. Circulation 41, 149–151 (1970).
Friend, D.G., O’Hare, J.P., Levine, H.D.: Action of triethanolamine trinitrate in angina pectoris. Amer. Heart J. 48, 775–779 (1954).
Ganz, W., Marcus, H.S.: Failure of intracoronary nitroglycerin to alleviate pacing-induced angina. Circulation 46, 880–889 (1972).
Goldbarg, A.N., Moran, J.F., Butterfield, T.K., Nemickas, R., Bermudez, G.A.: Therapy of angina pectoris with propranolol and long-acting nitrates. Circulation 40, 847–853 (1969).
Goldstein, R.E., Redwood, D.R., Epstein, S.E.: Isosorbide dinitrate in angina. Circulation 44, 1148–1149 (1971) (Letter to the Editor).
Goldstein, R.E., Rosing, D.R., Redwood, D.R., Beiser, G.D., Epstein, S.E.: Clinical and circulatory effects of isosorbide dinitrate: comparison with nitroglycerin. Circulation 43, 629–640 (1971).
Gorlin, R., Brachfeld, N., MacLeod, C., Bopp, P.: Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work. Circulation 19, 705–718 (1959).
Horwitz, L.D., Gorlin, R., Taylor, W.J., Kemp, H.G.: Effects of nitroglycerin on regional myocardial blood flow in coronary artery disease. J. clin. Invest. 50, 1578–1584 (1971).
Horwitz, L.D., Herman, M.V., Gorlin, R.: Clinical response to nitroglycerin as a diagnostic test for coronary artery disease. Amer. J. Cardiol. 29, 149–153 (1972).
Kalmanson, G.M., Drenick, E.J., Binder, M. J., Rosove, L.: Pentaerythritol tetranitrate in the treatment of angina pectoris. Arch. intern. med. 95, 819–822 (1955).
Klaus, A., Zaret, B., Pitt, B., Ross, R.S.: Comparative evaluation of sublingual long acting nitrates in angina pectoris. Amer. J. Cardiol. 31, 142 (1973) (Abstract).
Lange, R.L., Reid, M.S., Tresch, D.D., Keelan, M.H., Bernhard, V.M., Coolidge, G.: Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation 46, 666–678 (1972).
Livesley, B., Catley, P.F., Campbell, R.C., Oram, S.: Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris. Brit. med. J. 1973 I, 375–378.
MacAlpin, R.N., Alvaro, A.B., Kattus, A.A.: Effect of propranolol and nitroglycerin on exercise tolerance in angina pectoris, in Kattus, A. A., Ross, G., Hall, V., editors: UCLA forum in medical sciences No. 13. Cardiovascular beta adrenergic responses, pp. 191–203. Berkeley-Los Angeles-London: University of California Press 1970.
Mason, D.T., Braunwald, E.: The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm. Circulation 32, 755–766 (1961).
Master, A.M., Jaffe, H.L., Dack, S.: The drug treatment of angina pectoris due to coronary artery disease. Amer. J. med. Sci 197, 774–782 (1939).
Modell, W.: Clinical pharmacology of antianginal drugs. Clin. pharm. Ther. 3, 97–108 (1962).
Needleman, P.: Tolerance to the vascular effects of glyceryl trinitrate. J. Pharmacol. exp. Ther. 171, 98–102 (1970).
Needleman, P.: Oral nitrates: Efficacious? Ann. intern. med. 78, 458 (1973).
Needleman, P., Lang, S., Johnson, E. M.: Organic nitrates: relationship between biotransformation and rational angina pectoris therapy. J. Pharmacol. exp. Ther. 181, 489–497 (1972).
Nickerson, M.: Vasodilator drugs. In Goodman, L.S. and Gilman, A. (Eds.): The Pharmacological Basis of Therapeutics, p. 748. New York: Macmillan Co. 1965.
Oram, S., Sowton, E.: Failure of propatylnitrate and pentaerythritol tetranitrate to prevent attacks of angina pectoris. Brit. med. J. 1961 II, 1745–1746.
Parker, J.O., West, R.P., DiGiorgi, S.: The effect of nitroglycerin on coronary blood flow and the hemodynamic response to exercise in coronary artery disease. Amer. J. Cardiol. 27, 59 – 65 (1971).
Riseman, J.E.F., Brown, M.G.: The duration of attacks of angina pectoris on exertion and the effect of nitroglycerin and amyl nitrite. New Engl. J. med. 217, 470–473 (1937).
Rowe, G.G.: Coronary vasodilator therapy for angina pectoris. Amer. Heart J. 68, 691–696 (1964).
Rowe, G.G., Chelius, C.J., Afonso, S., Gurtner, H.P., Crumpton, C.W.: Systemic and coronary hemodynamic effects of erythrol tetranitrate. J. clin. Invest. 40, 1217–1222 (1961).
Russek, H.I.: Propranolol and isosorbide dinitrate synergism in angina pectoris. Amer. J. Cardiol. 21, 44–54 (1968).
Sandler, G., Ilahi, M.A., Lawson, C.W.: Glyceryl trinitrate in angina pectoris. Lancet 1963 I, 1130–1136.
Schelling, J.L., Lasagna, L.: A study of cross-tolerance to circulatory effects of organic nitrates. Clin. pharm. Ther. 8, 256–260 (1967).
Stipe, A.A., Fink, G.B.: Prophylactic therapy of angina pectoris with organic nitrates: Relationship of drug efficacy and clinical experimental design. J. clin. Pharmacol. 13, 244–250 (1973).
Wang, J., Mathur, V.S., Messer, J. V.: Nitroglycerine induced flow maldistribution in coronary stenosis. Circulation 44 (Suppl II). 59 (1971) (Abstract).
Williams, J. F., Jr., Glick, G., Braunwald, E.: Studies on cardiac dimensions in intact unanesthetized man. V. Effects of nitroglycerin. Circulatipn 32, 767–771 (1965).
Willis, P.W. III, Duff, I. F.: Coronary vasodilating drugs. Med. clin. N. Amer. 41, 449–469,1957.
Zelis, R., Mason, D.T.: Demonstration of nitrite tolerance: Attenuation of the vasodilator response to nitroglycerin by the chronic administration of isosorbide dinitrate. Circulation 40 (Suppl. III), 221 (1969) (Abstract).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Aronow, W.S. (1975). Use of Nitrates as Antianginal Agents. In: Needleman, P. (eds) Organic Nitrates. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 40. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66024-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-66024-5_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66026-9
Online ISBN: 978-3-642-66024-5
eBook Packages: Springer Book Archive